Aetna Medical Policy Updates – May 2018

Click here to view the Aetna Medical Policy Updates »

May 2018 Medical Policy Updates:

• Actinic Keratoses Treatments
• Adalimumab (Humira)
• Alpha 1-Antitrypsin Inhibitor Therapy
• Antineoplaston Therapy and Sodium Phenylbutyrate
• Back Pain – Invasive Procedures
• Brentuximab (Adcetris)
• Cardiac Event Monitors
• Certolizumab Pegol (Cimzia)
• Chelation Therapy
• Computerized Corneal Topography
• Contact Lenses and Eyeglasses
• Deep Brain Stimulation
• Dental Services and Oral and Maxillofacial Surgery: Coverage Under Medical Plans
• Electroencephalographic (EEG) Video Monitoring
• Erythropoiesis Stimulating Agents
• External Breast Prosthesis
• Eyelid Surgery
• Fetal Echocardiograms
• Fiberoptic Endoscopic Evaluation of Swallowing (FEES)/Fiberoptic Endoscopic Evaluation of Swallowing with Sensory Testing (FEESST)
• Frenectomy or Frenotomy for Ankyloglossia
• General Anesthesia and Monitored Anesthesia Care for Oral and Maxillofacial Surgery and Dental Services
• Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia
• Home Uterine Activity Monitoring
• Hospitalization for the Initiation of Ketogenic Diet for the Treatment of Intractable Seizures
• Infliximab – Medical Clinical Policy Bulletins | Aetna
• Iontophoresis
• Learning Disabilities, Dyslexia, and Vision
• Lyme Disease and other Tick-Borne Diseases
• Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) of the Spine
• Multiple Sclerosis
• Natalizumab (Tysabri)
• Nivolumab (Opdivo)
• Open Air, Low Field Strength, and Positional Magnetic Resonance Imaging (MRI) Units
• Parenteral Immunoglobulins
• Progestins
• Prolotherapy
• Respiratory Devices: Incentive Spirometers, Vaporizers and Intermittent Positive Pressure Breathing Machines
• Spinal Surgery: Laminectomy and Fusion
• Surface Scanning and Macro Electromyography
• Tracheostomy Supplies
• Tumor Chemosensitivity Assays
• Urinary Incontinence
• Ustekinumab (Stelara)
• Vedolizumab (Entyvio)
• Vocal Cord Paralysis/Insufficiency Treatments

Added 5/18/2018;

• Gonadotropin-Releasing Hormone Analogs and Antagonists
• Etanercept
• Trastuzumab (Herceptin), Ado-Trastuzumab (Kadcyla) and Pertuzumab (Perjeta)
• Parkinson’s Disease
• Xerostomia: Selected Treatments
• Tilt Table Testing
• Corneal Graft with Amniotic Membrane Transplantation, Limbal Stem Cell Transplantation, or Sural Nerve Grafting
• Stereotactic Cingulotomy
• Plasmapheresis/Plasma Exchange/Therapeutic Apheresis
• Ablation of Hepatic Lesions
• Proton Beam and Neutron Beam Radiotherapy
• Diabetes Tests, Programs and Supplies
• Cardioverter-Defibrillators

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.